Yosemite will fund companies through both grants and venture investing. The fund will target early-stage companies in therapeutics, diagnostics and digital health, according to an Aug. 1 Yosemite news release provided to Becker’s.
Yosemite is partnering with hospitals, endowments and global family offices.
“We’re on a mission to lead the next chapter in the fight against cancer and forming our own standalone entity provides us the flexibility to best propel great ideas until they’re at scale,” Mr. Jobs said. “We believe this first close demonstrates investor confidence in Yosemite’s strategy of building new companies, trust in our extensive grantee and institutional network, and value in our combined experience in shepherding new transformational cancer treatments.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.